Al-Mohaya S, Sadat-Ali M, Al-Muhanna F, Ibrahim-Saeed A
Department of General Surgery, King Faisal University Hospital, Al-Khobar, Saudi Arabia.
Angiology. 1989 Jun;40(6):569-73. doi: 10.1177/000331978904000609.
The authors report an analysis of 57 subclavian vein catheterizations for hemodialysis. A total of 51 patients (34 men, 17 women) kept the Cobe single- and double-lumen catheters for 1,726 days. The youngest patient was eighteen and the oldest seventy-two years of age. There were no catheter-related deaths. Complications were encountered in 9 patients. The only life-threatening complication was cardiac arrest, which occurred during flushing of the catheter. The patient was successfully revived. The other complications were pneumothorax and hydrothorax in 1 patient, catheter site infection in 5 patients, and arrhythmias in 2 patients, which stopped after readjustment of the catheter tips. Their experience indicates that percutaneous subclavian vein catheterization is safe and provides quick access for hemodialysis with no morbidity and mortality if done correctly, patiently, and meticulously. The authors believe that this should be the first choice in patients with reversible renal failure and in patients with chronic renal failure, who are usually elderly and medically compromised, till a permanent vascular access is ready for use.
作者报告了一项针对57例用于血液透析的锁骨下静脉置管的分析。共有51例患者（34名男性，17名女性）使用科贝单腔和双腔导管达1726天。最年轻的患者18岁，最年长的72岁。无导管相关死亡病例。9例患者出现并发症。唯一危及生命的并发症是心脏骤停，发生在导管冲洗过程中。患者成功复苏。其他并发症包括1例气胸和血胸、5例导管部位感染以及2例心律失常，经调整导管尖端后心律失常停止。他们的经验表明，经皮锁骨下静脉置管是安全的，若操作正确、耐心且细致，可为血液透析提供快速通路，且无发病率和死亡率。作者认为，对于可逆性肾衰竭患者以及通常为老年且存在医学问题的慢性肾衰竭患者，在永久性血管通路准备好使用之前，这应是首选方法。
